- Home
- GERN vs HMN Comparison
GERN vs HMN Comparison
Compare GERN & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- HMN
- Stock Information
- Founded
- GERN 1990
- HMN 1945
- Country
- GERN United States
- HMN United States
- Employees
- GERN N/A
- HMN N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- HMN Property-Casualty Insurers
- Sector
- GERN Health Care
- HMN Finance
- Exchange
- GERN Nasdaq
- HMN Nasdaq
- Market Cap
- GERN 1.5B
- HMN 1.7B
- IPO Year
- GERN 1996
- HMN 1991
- Fundamental
- Price
- GERN $1.59
- HMN $42.68
- Analyst Decision
- GERN Buy
- HMN Hold
- Analyst Count
- GERN 11
- HMN 3
- Target Price
- GERN $5.80
- HMN $44.50
- AVG Volume (30 Days)
- GERN 14.3M
- HMN 200.5K
- Earning Date
- GERN 05-01-2025
- HMN 05-07-2025
- Dividend Yield
- GERN N/A
- HMN 3.28%
- EPS Growth
- GERN N/A
- HMN 127.61
- EPS
- GERN N/A
- HMN 2.48
- Revenue
- GERN $76,994,000.00
- HMN $1,595,200,000.00
- Revenue This Year
- GERN $208.83
- HMN $9.64
- Revenue Next Year
- GERN $57.49
- HMN $6.00
- P/E Ratio
- GERN N/A
- HMN $17.21
- Revenue Growth
- GERN 32386.92
- HMN 6.92
- 52 Week Low
- GERN $1.46
- HMN $31.81
- 52 Week High
- GERN $5.34
- HMN $43.53
- Technical
- Relative Strength Index (RSI)
- GERN 32.05
- HMN 59.49
- Support Level
- GERN $1.63
- HMN $40.66
- Resistance Level
- GERN $1.89
- HMN $43.28
- Average True Range (ATR)
- GERN 0.11
- HMN 0.84
- MACD
- GERN 0.03
- HMN 0.09
- Stochastic Oscillator
- GERN 16.67
- HMN 81.76
Stock Price Comparison Chart: GERN vs HMN
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The company uses several former teachers in its salesforce. Its segments include Property and Casualty, Supplemental & Group Benefits, Life & Retirement, and Corporate and Other.